Skip to Content

C170 (Darifenacin Hydrobromide Extended-Release 7.5 mg)

Pill with imprint C170 is Yellow, Round and has been identified as Darifenacin Hydrobromide Extended-Release 7.5 mg. It is supplied by Par Pharmaceutical, Inc..

Darifenacin is used in the treatment of urinary frequency; overactive bladder; urinary incontinence and belongs to the drug class urinary antispasmodics. Risk cannot be ruled out during pregnancy. Darifenacin 7.5 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for C170

Darifenacin hydrobromide extended-release 7.5 mg C170

Darifenacin Hydrobromide Extended-Release

Imprint
C170
Strength
7.5 mg
Color
Yellow
Size
8.00 mm
Shape
Round
Availability
Prescription only
Drug Class
Urinary antispasmodics
Pregnancy Category
C - Risk cannot be ruled out
CSA Schedule
Not a controlled drug
Labeler / Supplier
Par Pharmaceutical, Inc.
National Drug Code (NDC)
10370-0170
Inactive Ingredients
calcium phosphate dibasic anhydrous, hypromellose 2208 (3 mPa.s), lactose monohydrate, magnesium stearate, polyvinyl alcohol, magnesium silicate, polyethylene glycol, titanium dioxide, D&C Yellow No. 10, FD&C Yellow No. 6

Note: Inactive ingredients may vary.

Get help with Imprint Code FAQs.

Related Images for "C170"

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.